SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-24-012413
Filing Date
2024-06-11
Accepted
2024-06-11 18:47:22
Documents
1
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 5716
  Complete submission text file 0001062993-24-012413.txt   7340
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Issuer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Khattar Jack A. (Reporting) CIK: 0001539937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40886 | Film No.: 241037089